Article

Macrophage activation in obese type 2 diabetes: an enhanced risk for COVID-19 and Acute…

Research square · 2020 · Abu Moin, author Thozhukat Sathyapalan, author Ilhame Diboun, author Stephen Atkin, author Alexandra Butler, author

Key facts

Title Macrophage activation in obese type 2 diabetes: an enhanced risk for COVID-19 and Acute Respiratory Distress Syndrome?
First author Abu Moin, author Thozhukat Sathyapalan, author Ilhame Diboun, author Stephen Atkin, author Alexandra Butler, author
Journal Research square
Published Nov 10, 2020
DOI 10.21203/rs.3.rs-95244/v2
Devices mentioned K000331, K000410, K000494, K000606, K001458, K003196, K003488, K010597, K010748, K011465, K013076, K013978 and 47 more
Product codes mentioned CDQ, CDT, CEK, CEO, CFJ, CFR, CGA, CGS, CGX, CHH, CHI, CIG and 67 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature